Infusional FOLFOX Plus Camrelizumab and Apatinib Versus HAIC-FOLFOX Plus Camrelizumab and Apatinib for Hepatocellular Carcinoma of BCLC C Stage: A Multi-center Randomized Phase III Trial
Latest Information Update: 03 Jul 2024
At a glance
- Drugs Camrelizumab (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Rivoceranib (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
Most Recent Events
- 29 May 2024 Trial design discussed in 60th Annual Meeting of the American Society of Clinical Oncology
- 18 Dec 2023 New trial record